Azienda Ospedaliera Vito Fazzi

Lecce 73100

0 studies enrolling now · 7 studies all time

What they study most

Atrial Fibrillation, Carcinoma, Non-Small-Cell Lung, Metastatic Castration-sensitive Prostate Cancer, Percutaneous Coronary Intervention, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL), Prostatic Neoplasms, Castration-Resistant, Urinary Bladder Neoplasms, Venous Thromboembolism

Studies at this site

• A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer — Running, not enrolling
• A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) — Running, not enrolling
• A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) — Completed
• A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia — Running, not enrolling
• RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism — Completed
• Real World Data on Gi(l)Otrif® Dose Adjustment — Completed
• Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) — Completed